HL7 Terminology (THO)
6.1.0 - Publication
This page is part of the HL7 Terminology (v6.1.0: Release) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
Active as of 2023-07-28 | Maturity Level: 1 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="adverse-event-clinical-research-grades"/>
<meta>
<profile
value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet adverse-event-clinical-research-grades</b></p><a name="adverse-event-clinical-research-grades"> </a><a name="hcadverse-event-clinical-research-grades"> </a><a name="adverse-event-clinical-research-grades-en-US"> </a><ul><li>Include these codes as defined in <a href="CodeSystem-v3-nciThesaurus.html"><code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C41338</td><td>Grade 1 Mild Adverse Event</td></tr><tr><td>C41339</td><td>Grade 2 Moderate Adverse Event</td></tr><tr><td>C41340</td><td>Grade 3 Severe Adverse Event</td></tr><tr><td>C41337</td><td>Grade 4 Life Threatening or Disabling Adverse Event</td></tr><tr><td>C48275</td><td>Grade 5 Death Related to Adverse Event</td></tr></table></li></ul></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="brr"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
<valueInteger value="1"/>
</extension>
<url
value="http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-grades"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.11.21027"/>
</identifier>
<version value="1.0.0"/>
<name value="AdverseEventClinicalResearchGrades"/>
<title value="Adverse Event Clinical Research Grades"/>
<status value="active"/>
<experimental value="false"/>
<date value="2023-07-28T19:27:19+00:00"/>
<publisher value="Health Level Seven International"/>
<contact>
<telecom>
<system value="url"/>
<value value="http://hl7.org"/>
</telecom>
<telecom>
<system value="email"/>
<value value="hq@HL7.org"/>
</telecom>
</contact>
<description
value="Value set of grades used in Adverse Event Clinical Research, especially in Oncology clinical trials"/>
<copyright
value="This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html"/>
<compose>
<include>
<system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/>
<concept>
<code value="C41338"/>
<display value="Grade 1 Mild Adverse Event"/>
</concept>
<concept>
<code value="C41339"/>
<display value="Grade 2 Moderate Adverse Event"/>
</concept>
<concept>
<code value="C41340"/>
<display value="Grade 3 Severe Adverse Event"/>
</concept>
<concept>
<code value="C41337"/>
<display value="Grade 4 Life Threatening or Disabling Adverse Event"/>
</concept>
<concept>
<code value="C48275"/>
<display value="Grade 5 Death Related to Adverse Event"/>
</concept>
</include>
</compose>
</ValueSet>